Buspar
Showing 1 - 23 of 23
Spinal Cord Injuries Trial in Cambridge (Buspirone, Placebo)
Recruiting
- Spinal Cord Injuries
- Buspirone
- Placebo
-
Cambridge, MassachusettsSpaulding Hospital Cambridge
Jan 5, 2022
Traumatic Brain Injury Trial in Indianapolis (Buspirone, Placebo)
Recruiting
- Traumatic Brain Injury
- Buspirone
- Placebo
-
Indianapolis, IndianaIndiana University and Rehabilitation Hospital of Indiana
Jan 19, 2022
A Multicenter, Prospective, OS to Evaluate Quality of Life and
Recruiting
- Depressive Disorder, Major
- Anxiety Disorders
-
Seoul, Yeouido, Korea, Republic ofthe Catholic University of Korea, Yeouido St. Mary's Hospital
Oct 21, 2021
Spinal Cord Injuries Trial in Cambridge (drug, device, other)
Recruiting
- Spinal Cord Injuries
- Buspirone Hydrochloride
- +4 more
-
Cambridge, MassachusettsSpaulding Hospital Cambridge
Aug 4, 2021
Autism Spectrum Disorder (ASD) Trial in Boston (Buspirone, Placebo)
Withdrawn
- Autism Spectrum Disorder (ASD)
- Buspirone
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Jul 8, 2021
Opioid-Related Disorders, Dependency (Psychology), Pain, Chronic Trial in Baltimore (Buspirone oral capsule, Placebo oral
Completed
- Opioid-Related Disorders
- +3 more
- Buspirone oral capsule
- Placebo oral capsule
-
Baltimore, MarylandJohns Hopkins University
Jul 21, 2020
Healthy Trial in Fargo (BUSPAR® 30 mg Tablet, Buspirone Hydrochloride 30 mg Tablet)
Completed
- Healthy
- BUSPAR® 30 mg Tablet
- Buspirone Hydrochloride 30 mg Tablet
-
Fargo, North DakotaPRACS Institute, Ltd.
Jan 6, 2020
Healthy Trial in Fargo (BUSPAR® 30 mg Tablet, Buspirone Hydrochloride 30 mg Tablet)
Completed
- Healthy
- BUSPAR® 30 mg Tablet
- Buspirone Hydrochloride 30 mg Tablet
-
Fargo, North DakotaPRACS Institute, Ltd.
Jan 6, 2020
Autism Spectrum Disorders, Anxiety Trial in Boston (Buspirone)
Active, not recruiting
- Autism Spectrum Disorders
- Anxiety
-
Boston, MassachusettsMassachusetts General Hospital
Mar 30, 2022
Autism Spectrum Disorder, Anxiety Trial in Boston (Buspirone)
Not yet recruiting
- Autism Spectrum Disorder
- Anxiety
-
Boston, MassachusettsMassachusetts General Hospital
Jan 11, 2022
Functional Dysphagia, Ineffective Esophageal Motility Trial (Buspirone, Placebo)
Completed
- Functional Dysphagia
- Ineffective Esophageal Motility
- Buspirone
- Placebo
- (no location specified)
Jul 10, 2018
To Determine Bioequivalence Under Fed Conditions Trial in St-Laurent (Buspirone HCl, Buspar)
Completed
- To Determine Bioequivalence Under Fed Conditions
- Buspirone HCl
- Buspar
-
St-Laurent, Quebec, CanadaPhoenix International Life Sciences inc
Sep 22, 2017
Cocaine Dependence Trial in Houston (Buspirone, Placebo for Buspirone, Methylphenidate)
Completed
- Cocaine Dependence
- Buspirone
- +3 more
-
Houston, TexasThe University of Texas Health Science Center at Houston
May 3, 2017
Marijuana Dependence Trial in Charleston (Buspirone, Placebo)
Completed
- Marijuana Dependence
- Buspirone
- Placebo
-
Charleston, South CarolinaMedical University of South Carolina
Jul 8, 2016
Schizophrenia, Schizoaffective Disorder Trial in Nashville (adjunctive treatment with buspirone, )
Completed
- Schizophrenia
- Schizoaffective Disorder
- adjunctive treatment with buspirone
- placebo
-
Nashville, TennesseePsychiatric Hospital at Vanderbilt
Jun 5, 2017
Alzheimer's Disease, Mild Cognitive Impairment Trial in Boston (Beta amyloid imaging)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Beta amyloid imaging
-
Boston, MassachusettsTufts Medical Center
Feb 22, 2017
Anxiety Disorder Trial in Seoul (buspirone+alprazolam, alprazolam)
Withdrawn
- Anxiety Disorder
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 19, 2015
Cocaine Dependence Trial in United States (Buspirone, Placebo)
Smoking Cessation, Tobacco Use Cessation Trial in Toronto (Buspirone, Placebo)
Completed
- Smoking Cessation
- Tobacco Use Cessation
- Buspirone
- Placebo
-
Toronto, Ontario, CanadaCenter for Addiction and Mental Health
Jun 3, 2014
MDD Trial in United States (BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet
Completed
- Major Depressive Disorder
- BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet 3 mg QD
- +2 more
-
Garden Grove, California
- +8 more
Jun 17, 2014
Attention Deficit Disorder With Hyperactivity Trial in United States (Atomoxetine, Buspirone)
Completed
- Attention Deficit Disorder With Hyperactivity
-
Los Angeles, California
- +10 more
Jul 10, 2008
To Determine Bioequivalence Under Fasting Conditions Trial in St-Laurent (buspirone HCl, Buspar)
Completed
- To Determine Bioequivalence Under Fasting Conditions
- buspirone HCl
- Buspar
-
St-Laurent, Quebec, CanadaPhoenix International Life Sciences, Inc.
Apr 1, 2008